Key result
Remimazolam provided successful monitored anesthesia care with hemodynamic stability and appropriate sedation in a parturient with severe cardiac disease undergoing dilation and curettage.
Case Report (n=1)
Remimazolam may be a safe and effective sedative for patients with complex cardiac comorbidities undergoing short procedures due to its stable hemodynamic profile.
May support remimazolam in select cardiac cases; hypothesis-generating pending controlled trials.
We report a case of a parturient with severe cardiac disease requiring elective termination of pregnancy. The patient underwent successfully monitored anesthesia care using remimazolam for dilation and curettage. The patient remained hemodynamically stable and appropriately sedated while achieving optimal procedural conditions. Remimazolam is an ultrashort acting benzodiazepine that is being used with increasing frequency in short procedures requiring sedation. Patients with complex cardiac comorbidities undergoing surgical procedures may receive maximum benefit from this novel medication due to its stable hemodynamic profile and rapid metabolism.
No takes yet. Share an insight, caveat, or question.
Kemp et al. (2025) conducted a case report in Severe cardiac disease in a parturient (n=1). Remimazolam was evaluated on Hemodynamic stability and sedation. Remimazolam provided successful monitored anesthesia care with hemodynamic stability and appropriate sedation in a parturient with severe cardiac disease undergoing dilation and curettage.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: